GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Global Health MEDANTA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,427.10

+2.85%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹44.10bn

FY2018FY2026

Net income

₹5.56bn

FY2018FY2026

Free cash flow

−₹2.25bn

FY2018FY2026

Shareholders' equity

₹39.62bn

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue₹44.10bn₹36.37bn₹32.41bn₹26.83bn₹21.67bn₹14.29bn₹14.81bn₹14.41bn₹13.68bn
Research and development₹3.0m₹4.1m₹420,000₹340,000₹590,000₹270,000₹120,000₹300,000₹20.7m
Operating income₹6.97bn₹7.37bn₹6.58bn₹4.99bn₹3.25bn₹927.0m₹969.5m₹724.3m₹1.66bn
Net income₹5.56bn₹4.81bn₹4.78bn₹3.26bn₹1.96bn₹288.1m₹363.3m₹513.0m₹328.7m
Diluted earnings per share20.6817.9417.8012.137.501.141.351.911.22

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets₹59.05bn₹47.66bn₹43.04bn₹41.16bn₹31.46bn₹26.94bn₹26.66bn₹24.74bn₹19.84bn
Cash and short-term investments₹11.30bn₹10.51bn₹11.56bn₹12.60bn₹5.12bn₹2.89bn₹2.50bn₹2.66bn₹2.60bn
Total liabilities₹19.21bn₹13.79bn₹13.98bn₹16.88bn₹15.30bn₹13.12bn₹13.17bn₹11.44bn₹7.67bn
Debt₹11.90bn₹7.18bn₹8.02bn₹11.22bn₹11.09bn₹9.31bn₹9.29bn₹7.66bn₹4.23bn
Shareholders' equity₹39.62bn₹33.86bn₹29.06bn₹24.28bn₹16.16bn₹13.82bn₹13.50bn₹12.95bn₹12.17bn
Shares outstanding269m268m269m269m262m253m269m269m269m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations₹7.53bn₹6.24bn₹6.12bn₹6.45bn₹3.11bn₹2.42bn₹1.75bn₹1.54bn—
Capital spending−₹9.79bn−₹5.17bn−₹2.79bn−₹2.36bn−₹2.74bn−₹1.46bn−₹1.88bn−₹3.00bn—
Free cash flow−₹2.25bn₹1.07bn₹3.33bn₹4.09bn₹367.9m₹960.3m−₹132.0m−₹1.45bn—
Dividends paid−₹134.4m————————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹13.04bn₹11.59bn₹11.21bn₹10.99bn₹10.31bn₹8.76bn₹9.43bn₹9.57bn
Operating income₹2.18bn₹1.77bn₹1.56bn₹1.81bn₹1.82bn₹2.14bn₹1.89bn₹1.79bn
Net income₹1.59bn₹1.44bn₹950.2m₹1.58bn₹1.59bn₹1.01bn₹1.43bn₹1.31bn
Diluted earnings per share5.905.353.545.905.923.785.324.87
Cash from operations———₹3.29bn————
Capital spending———−₹4.13bn————
Free cash flow———−₹842.0m————
Total assets—₹59.05bn—₹54.10bn—₹47.66bn—₹45.10bn
Cash and short-term investments₹11.30bn₹11.30bn₹12.20bn₹12.55bn₹11.22bn₹11.22bn₹9.83bn₹10.19bn
Debt—₹6.64bn—₹5.51bn—₹3.58bn—₹3.41bn
Shareholders' equity₹39.84bn₹39.62bn₹37.10bn₹37.08bn₹33.88bn₹33.86bn₹31.43bn₹31.41bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.0%25.3%—
Operating income11.8%49.7%—
Net income19.5%80.8%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings67.966.160.679.162.4
Price to sales8.68.88.99.65.7

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 22 Aug 2025.

FY2026
Paid in the year0.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.